Company Filing History:
Years Active: 2023
Title: Kari Wiedinger: Innovator in RNA Modulation
Introduction
Kari Wiedinger is a notable inventor based in New Providence, NJ (US). He has made significant contributions to the field of RNA modulation, holding 2 patents that focus on innovative methods for altering RNA splicing and gene expression.
Latest Patents
Wiedinger's latest patents include groundbreaking work on "Methods for Modulating RNA Splicing." One aspect of this patent describes an intronic recognition element for splicing modifier (iREMS) that can be recognized by a compound provided in the patent. The methods outlined aim to modulate the amount of a product of a gene, utilizing a precursor RNA transcript that contains an intronic REMS. Additionally, the patents detail artificial gene constructs that incorporate an intronic REMS, which can be used to enhance protein production. Another patent focuses on methods for modifying RNA splicing to regulate the amount of RNA transcripts or protein products encoded by genes, employing a small molecule splicing modifier compound.
Career Highlights
Kari Wiedinger is currently associated with Ptc Therapeutics, Inc., where he continues to advance his research in RNA modulation. His work is pivotal in understanding and manipulating gene expression, which has far-reaching implications in biotechnology and medicine.
Collaborations
Wiedinger collaborates with talented professionals in his field, including Anuradha Bhattacharyya and Amal Dakka. These collaborations enhance the innovative potential of his research and contribute to the development of new therapeutic strategies.
Conclusion
Kari Wiedinger's contributions to RNA modulation through his patents and work at Ptc Therapeutics, Inc. highlight his role as a leading inventor in the field. His innovative approaches to gene expression modulation are paving the way for future advancements in biotechnology.